Page last updated: 2024-09-03

omega-n-methylarginine and Cardiovascular Stroke

omega-n-methylarginine has been researched along with Cardiovascular Stroke in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (35.29)18.2507
2000's9 (52.94)29.6817
2010's2 (11.76)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arós, F; Clish, CB; Corella, D; Estruch, R; Fitó, M; Gómez-Gracia, E; Guasch-Ferré, M; Hruby, A; Hu, FB; Lapetra, J; Liang, L; Martínez-González, MA; Romaguera, D; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Serra-Majem, L; Toledo, E; Wang, DD; Yu, E1
Gonon, AT; Kiss, A; Pernow, J; Sjöquist, PO; Tratsiakovich, Y; Yang, J1
Genda, S; Ichikawa, Y; Miki, T; Miura, T; Shimamoto, K1
Hirooka, Y; Kimura, Y; Kishi, T; Shigematsu, H; Takeshita, A; Ueta, Y1
Hirooka, Y; Ito, K; Kishi, T; Sakai, K; Shigematsu, H; Shimokawa, H; Sunagawa, K; Takeshita, A1
Alexander, JH; Baran, DA; Buller, CE; Cantor, WJ; Cotter, G; Dzavík, V; Farkouh, ME; Gross, SS; Harrington, RA; Hathaway, D; Hazen, SL; Hochman, JS; Holmes, DR; Kleiman, NS; Ohman, EM; Panza, JA; Parrillo, JE; Prondzinsky, R; Ramanathan, K; Reynolds, HR; Stebbins, AL; Vered, Z; Webb, JG1
Baker, JE; Fu, X; Gross, GJ; Hsu, A; Strande, JL; Su, J1
Higasa, S; Kakishita, E; Oku, KI; Seto, T; Suehiro, A; Yoshimoto, H1
Carmines, PK; Didion, SP; Ikenaga, H; Mayhan, WG1
Baron, AD; Fei, L; Henry, DP; Zipes, DP1
Doi, H; Kawano, H; Kugiyama, K; Matsumura, T; Misumi, K; Motoyama, T; Nakagawa, O; Nakajima, K; Nakano, T; Ogawa, H; Soejima, H; Sugiyama, S; Yasue, H; Yoshimura, M1
Buikema, H; Crijns, HJ; de Zeeuw, D; Monnink, SH; Tio, RA; van Gilst, WH1
Hasegawa, T; Kuno, A; Miki, T; Miura, T; Nakano, A; Shimamoto, K; Tsuchida, A1
Boulanger, CM; Ebrahimian, T; Henry, P; Mallat, Z; Mathieu, E; Scoazec, A; Tedgui, A1
Hasegawa, T; Kuno, A; Miki, T; Miura, T; Nishino, Y; Shimamoto, K; Tsuchida, A1
Christes, A; Drexler, H; Hablawetz, E; Lu, W; Riede, U1
Drexler, H; Lu, W1

Trials

1 trial(s) available for omega-n-methylarginine and Cardiovascular Stroke

ArticleYear
Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study.
    European heart journal, 2007, Volume: 28, Issue:9

    Topics: Aged; Enzyme Inhibitors; Female; Hemodynamics; Humans; Infusions, Intravenous; Male; Myocardial Infarction; Nitric Oxide Synthase; omega-N-Methylarginine; Shock, Cardiogenic

2007

Other Studies

16 other study(ies) available for omega-n-methylarginine and Cardiovascular Stroke

ArticleYear
Plasma Arginine/Asymmetric Dimethylarginine Ratio and Incidence of Cardiovascular Events: A Case-Cohort Study.
    The Journal of clinical endocrinology and metabolism, 2017, 06-01, Volume: 102, Issue:6

    Topics: Aged; Arginine; Cardiovascular Diseases; Case-Control Studies; Chromatography, Liquid; Citrulline; Cohort Studies; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; omega-N-Methylarginine; Ornithine; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke; Tandem Mass Spectrometry

2017
Inhibition of Rho kinase protects from ischaemia-reperfusion injury via regulation of arginase activity and nitric oxide synthase in type 1 diabetes.
    Diabetes & vascular disease research, 2017, Volume: 14, Issue:3

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Arginase; Arginine; Cytoprotection; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide Synthase; omega-N-Methylarginine; Protein Kinase Inhibitors; Rats, Sprague-Dawley; rho GTP-Binding Proteins; rho-Associated Kinases; Signal Transduction

2017
K(ATP) channel opening is an endogenous mechanism of protection against the no-reflow phenomenon but its function is compromised by hypercholesterolemia.
    Journal of the American College of Cardiology, 2002, Oct-02, Volume: 40, Issue:7

    Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Chronic Disease; Coronary Circulation; Disease Models, Animal; Glyburide; Hemodynamics; Hypercholesterolemia; Male; Myocardial Infarction; Nicorandil; Nitric Oxide Synthase; omega-N-Methylarginine; Potassium Channel Blockers; Potassium Channels; Rabbits; Vasodilator Agents

2002
Reduced nitric oxide synthase in the brainstem contributes to enhanced sympathetic drive in rats with heart failure.
    Journal of cardiovascular pharmacology, 2003, Volume: 42 Suppl 1

    Topics: Animals; Blood Pressure; Blotting, Western; Brain Stem; Disease Models, Animal; Echocardiography; Gene Expression; Heart Failure; Hemodynamics; In Situ Hybridization; Injections, Intraventricular; Male; Myocardial Infarction; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Norepinephrine; omega-N-Methylarginine; Organ Size; Rats; Rats, Inbred WKY; RNA, Messenger; Solitary Nucleus; Sympathetic Nervous System

2003
Overexpression of eNOS in brain stem reduces enhanced sympathetic drive in mice with myocardial infarction.
    American journal of physiology. Heart and circulatory physiology, 2005, Volume: 289, Issue:5

    Topics: Adenoviridae; Animals; beta-Galactosidase; Blood Pressure; Blotting, Western; Brain Stem; Coronary Vessels; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Gene Transfer Techniques; Heart Rate; Immunohistochemistry; Male; Mice; Myocardial Infarction; Nitric Oxide; Norepinephrine; omega-N-Methylarginine; Solitary Nucleus; Sympathetic Nervous System; Ventricular Function, Left

2005
SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
    Basic research in cardiology, 2007, Volume: 102, Issue:4

    Topics: Androstadienes; Animals; Cardiotonic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glyburide; Hirudins; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Oligopeptides; omega-N-Methylarginine; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Potassium Channel Blockers; Potassium Channels; Proto-Oncogene Proteins c-akt; Pyrroles; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor, PAR-1; Recombinant Proteins; Research Design; RNA, Messenger; Signal Transduction; Thrombin; Time Factors; Ventricular Function, Left; Wortmannin

2007
[Inhibitory effect of isosorbide dinitrate on whole blood aggregation].
    Journal of cardiology, 1997, Volume: 29, Issue:4

    Topics: Angina Pectoris; Blood; Cell Aggregation; Cyclic GMP; Female; Humans; In Vitro Techniques; Isosorbide Dinitrate; Leukocytes; Male; Methylene Blue; Middle Aged; Myocardial Infarction; omega-N-Methylarginine; Platelet Aggregation; Platelet Aggregation Inhibitors; Vasodilator Agents

1997
Enhanced constrictor responses of skeletal muscle arterioles during chronic myocardial infarction.
    The American journal of physiology, 1997, Volume: 273, Issue:3 Pt 2

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Arginine Vasopressin; Arterioles; Coronary Vessels; Endothelin-1; Hemodynamics; Male; Muscle, Skeletal; Muscle, Smooth, Vascular; Myocardial Infarction; omega-N-Methylarginine; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Sprague-Dawley; Reference Values; Thromboxane A2; Time Factors; Vasoconstriction; Vasoconstrictor Agents

1997
Intrapericardial delivery of L-arginine reduces the increased severity of ventricular arrhythmias during sympathetic stimulation in dogs with acute coronary occlusion: nitric oxide modulates sympathetic effects on ventricular electrophysiological properti
    Circulation, 1997, Dec-02, Volume: 96, Issue:11

    Topics: Animals; Arginine; Confounding Factors, Epidemiologic; Disease Models, Animal; Dogs; Electric Stimulation; Enzyme Inhibitors; Myocardial Contraction; Myocardial Infarction; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Pericardium; Severity of Illness Index; Tachycardia, Ventricular

1997
Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries.
    Circulation, 1998, Jun-30, Volume: 97, Issue:25

    Topics: Acetylcholine; Adult; Aged; Coronary Angiography; Coronary Circulation; Coronary Disease; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Lipoproteins; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; omega-N-Methylarginine; Risk Factors

1998
Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure.
    British journal of pharmacology, 2000, Volume: 130, Issue:8

    Topics: Acetylcholine; Acetylcysteine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Calcimycin; Captopril; Endothelium, Vascular; Heart Diseases; In Vitro Techniques; Lisinopril; Male; Myocardial Infarction; Nitrates; Nitrites; Nitroglycerin; omega-N-Methylarginine; Rats; Rats, Wistar; Sodium Nitrite; Sulfhydryl Compounds; Vasodilation; Vasodilator Agents

2000
Endothelium-dependent coronary response is impaired in the myocardium at an early phase of post-infarct remodeling.
    Japanese heart journal, 2000, Volume: 41, Issue:6

    Topics: Acetylcholine; Animals; Coronary Circulation; Coronary Vessels; Endothelium; Heart Rate; In Vitro Techniques; Male; Myocardial Infarction; Myocardium; Nitroprusside; omega-N-Methylarginine; Rabbits; Ventricular Pressure; Ventricular Remodeling

2000
Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction.
    Circulation, 2001, Nov-27, Volume: 104, Issue:22

    Topics: Adult; Animals; Aorta; Cell Membrane; Cell Membrane Structures; Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; In Vitro Techniques; Ionophores; Male; Middle Aged; Myocardial Infarction; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Particle Size; Rats; Rats, Wistar; Vasoconstrictor Agents; Vasodilator Agents; Vasomotor System

2001
Blockade of angiotensin II type 1 receptors suppressed free radical production and preserved coronary endothelial function in the rabbit heart after myocardial infarction.
    Journal of cardiovascular pharmacology, 2002, Volume: 39, Issue:1

    Topics: Acetylcholine; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Endothelium, Vascular; Enzyme Inhibitors; Free Radicals; Hemodynamics; In Vitro Techniques; Lipid Peroxides; Male; Myocardial Infarction; Myocardium; Nitroprusside; omega-N-Methylarginine; Oxygen; Rabbits; Receptor, Angiotensin, Type 1; Tetrazoles; Tiopronin; Valine; Valsartan; Vasodilator Agents; Ventricular Remodeling

2002
Effects of inhibition of nitric oxide formation on regional blood flow in experimental myocardial infarction.
    Circulation, 1992, Volume: 86, Issue:1

    Topics: Animals; Arginine; Blood Pressure; Coronary Circulation; Dipyridamole; Hemodynamics; Male; Myocardial Infarction; Nitric Oxide; Nitroglycerin; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Time Factors; Vascular Resistance

1992
Endothelial dysfunction of hindquarter resistance vessels in experimental heart failure.
    The American journal of physiology, 1992, Volume: 262, Issue:6 Pt 2

    Topics: Acetylcholine; Animals; Arginine; Blood Vessels; Cardiac Output, Low; Chronic Disease; Dose-Response Relationship, Drug; Endothelium, Vascular; Hindlimb; Male; Myocardial Infarction; Nitroglycerin; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Vascular Resistance

1992